 Hindu Business Line | Patented drug entry could be delayed in India: Deloitte Hindu Business Line Launch of patented drugs in India could be delayed due to the government's “thought process on linking patented drug prices to the country's per—capita income”, according to a report by consultancy firm Deloitte. ... Earlier in March this year ... |
